Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Killestein

Showing results (31-40 of 89) with videos related to

Pageof 9
Sort By:
Journal of Neuroimmunology|September 3, 2004
Osteopontin levels and increased disease activity in relapsing-remitting multiple sclerosis patientsM H J Vogt, S Floris, J Killestein, et al.
European Journal of Neurology|July 15, 2017
John Cunningham virus conversion in relation to natalizumab concentration in multiple sclerosis patientsZ L E van Kempen, C E Leurs, A de Vries, et al.
Neurology|March 14, 2012
A randomized trial of high-dose vitamin D2 in relapsing-remitting multiple sclerosisL Grimaldi, F Barkhof, M Beelke, et al.
Multiple Sclerosis and Related Disorders|February 12, 2026
Aging does not affect the relationship between OCT and clinical or MRI outcome measuresS Kaçar, Julia R Jelgerhuis, J Killestein, et al.
Case Reports in Neurological Medicine|December 16, 2014
PML-IRIS during Fingolimod Diagnosed after Natalizumab DiscontinuationJ Killestein, A Vennegoor, A E L van Golde, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 28, 2001
Intracellular cytokine profile in T-cell subsets of multiple sclerosis patients: different features in primary progressive diseaseJ Killestein, B F Den Drijver, W L Van der Graaff, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 20, 2007
No evidence of misdiagnosis in patients with multiple sclerosis and repeated positive anticardiolipin antibody testing based on magnetic resonance imaging and long term follow-upM Liedorp, E Sanchez, I M W van Hoogstraten, et al.
Neurology|October 1, 2010
Normal CSF ferritin levels in MS suggest against etiologic role of chronic venous insufficiencyV Worthington, J Killestein, M J Eikelenboom, et al.
Journal of Neuroimmunology|April 2, 2003
Immunomodulatory effects of orally administered cannabinoids in multiple sclerosisJ Killestein, E L J Hoogervorst, M Reif, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 21, 2013
Oxysterols and cholesterol precursors correlate to magnetic resonance imaging measures of neurodegeneration in multiple sclerosisC van de Kraats, J Killestein, V Popescu, et al.
Pageof 9

Showing results (31-40 of 89) with videos related to

Sort By:
Pageof 9
Journal of Neuroimmunology|September 3, 2004
Osteopontin levels and increased disease activity in relapsing-remitting multiple sclerosis patientsM H J Vogt, S Floris, J Killestein, et al.
European Journal of Neurology|July 15, 2017
John Cunningham virus conversion in relation to natalizumab concentration in multiple sclerosis patientsZ L E van Kempen, C E Leurs, A de Vries, et al.
Neurology|March 14, 2012
A randomized trial of high-dose vitamin D2 in relapsing-remitting multiple sclerosisL Grimaldi, F Barkhof, M Beelke, et al.
Multiple Sclerosis and Related Disorders|February 12, 2026
Aging does not affect the relationship between OCT and clinical or MRI outcome measuresS Kaçar, Julia R Jelgerhuis, J Killestein, et al.
Case Reports in Neurological Medicine|December 16, 2014
PML-IRIS during Fingolimod Diagnosed after Natalizumab DiscontinuationJ Killestein, A Vennegoor, A E L van Golde, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 28, 2001
Intracellular cytokine profile in T-cell subsets of multiple sclerosis patients: different features in primary progressive diseaseJ Killestein, B F Den Drijver, W L Van der Graaff, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 20, 2007
No evidence of misdiagnosis in patients with multiple sclerosis and repeated positive anticardiolipin antibody testing based on magnetic resonance imaging and long term follow-upM Liedorp, E Sanchez, I M W van Hoogstraten, et al.
Neurology|October 1, 2010
Normal CSF ferritin levels in MS suggest against etiologic role of chronic venous insufficiencyV Worthington, J Killestein, M J Eikelenboom, et al.
Journal of Neuroimmunology|April 2, 2003
Immunomodulatory effects of orally administered cannabinoids in multiple sclerosisJ Killestein, E L J Hoogervorst, M Reif, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 21, 2013
Oxysterols and cholesterol precursors correlate to magnetic resonance imaging measures of neurodegeneration in multiple sclerosisC van de Kraats, J Killestein, V Popescu, et al.
Pageof 9